NeuroDerm, Ltd.

49 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

May 2030

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

4 fees due Nov 26, 2026
1 fee due Feb 11, 2027
The maintenance fee for Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same (US 9,101,663) comes due Feb 11, 2027. Unpaid by Aug 11, 2027, it lapses early.
1 fee due Apr 10, 2027
The maintenance fee for Device for subcutaneous delivery of fluid medicament (US 11,779,697) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
2 fees due May 5, 2027
1 fee due Jun 19, 2027
The maintenance fee for Methods for treatment of Parkinson's disease (US 11,844,754) comes due Jun 19, 2027. Unpaid by Dec 20, 2027, it lapses early.
1 fee due Sep 30, 2027
The maintenance fee for Device for Subcutaneous Delivery of Fluid Medicament (US 10,603,430) comes due Sep 30, 2027. Unpaid by Mar 31, 2028, it lapses early.
1 fee due Oct 21, 2027
The maintenance fee for Dopa Decarboxylase Inhibitor Compositions (US 10,624,839) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 7,863,336	Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same In force Ends no later than May 17, 2030 · Medium confidence	In force	Ends no later than May 17, 2030	Medium confidence
US 8,193,243	Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same In force Ends no later than May 17, 2030 · Medium confidence	In force	Ends no later than May 17, 2030	Medium confidence
US 9,040,589	Continuous administration of dopa decarboxylase inhibitors and compositions for same In force Ends no later than May 17, 2030 · From the USPTO record	In force	Ends no later than May 17, 2030	From the USPTO record
US 9,040,590	Continuous administration of dopa decarboxylase inhibitors and compositions for same In force Ends no later than May 17, 2030 · From the USPTO record	In force	Ends no later than May 17, 2030	From the USPTO record
US 9,101,663	Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same In force Term ends May 17, 2030 · Medium confidence	In force	Term ends May 17, 2030	Medium confidence
US 9,993,451	Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same In force Term ends May 17, 2030 · Medium confidence	In force	Term ends May 17, 2030	Medium confidence
US 9,040,577	Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same In force Ends no later than Nov 15, 2031 · From the USPTO record	In force	Ends no later than Nov 15, 2031	From the USPTO record
US 9,040,578	Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same In force Ends no later than Nov 15, 2031 · From the USPTO record	In force	Ends no later than Nov 15, 2031	From the USPTO record
US 9,421,267	Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for Same In force Ends no later than Nov 15, 2031 · Medium confidence	In force	Ends no later than Nov 15, 2031	Medium confidence
US 9,415,108	Compositions for transdermal delivery of active agents In force Term ends Dec 20, 2032 · From the USPTO record	In force	Term ends Dec 20, 2032	From the USPTO record

10 of 49 patents shown.

Pro members see all 49.

Pro members: see all 49 patents

Also on record, not counted in the 49: 6 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

8 pending · 12 abandoned · 21 no status recorded

List them